Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 99, pseudogene (RNU6-99P) is a human pseudogene that is homologous to the gene encoding U6 small nuclear RNA, a critical non-coding RNA involved in the spliceosome complex responsible for pre-mRNA splicing[1][5]. RNU6-99P itself is classified as a pseudogene, which means it is generally considered non-functional at the protein-coding level, and there is no evidence it encodes a protein. However, some pseudogenes, including those derived from U6 small nuclear RNA genes, may be transcribed as non-coding RNAs, and recent research suggests that pseudogene-derived RNAs could be involved in regulatory functions such as acting as competing endogenous RNAs or being processed into small RNAs that modulate gene expression[2][4]. The specific functional role, disease association, or clinical utility of RNU6-99P remains undocumented in current genomic and biomedical databases[1][10]. **Key additional details:** - RNU6-99P is not a therapeutic target, receptor, enzyme, or transporter. It is one of many U6 snRNA pseudogenes found in the human genome and has no established role in drug interactions or direct disease mechanisms[1][10]. - Pseudogenes like RNU6-99P may participate in fine-tuning expression of parental genes or related pathways, especially by acting as decoys for miRNAs or producing regulatory small RNAs, but most remain uncharacterized on an individual basis[2][4]. No evidence of incorrectness or misspelling for "RNU6-99P"; the query is specific and accurate[1][10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 99, pseudogene (RNU6-99P).